News and blogs
This week, Frontline AIDS participated in the World Health Summit (WHS) in Berlin, a major global forum that gathers leaders from politics, science, the private sector, and civil society from around the world to address pressing global health challenges. Over three days, Frontline AIDS staff worked to build momentum around key priorities, including addressing female genital schistosomiasis (FGS) and achieving equity in the ongoing negotiations around the Pandemic Accord....
Donald Trump’s return to the White House for a second term inflicts a hammer blow to LGBTQ+ rights and access to abortion within the U.S., as well as putting HIV and sexual and reproductive health provision around the world at risk....
Frontline AIDS is celebrating its 30-year anniversary to create a future free from AIDS for everyone, everywhere in July 2024. ...
Frontline AIDS does not endorse political parties nor support candidates, but in the wake of the US election result we cannot deny the importance of its potential impact on our goal to end AIDS, as well as for people living with HIV and for marginalised communities who are often most affected. We know that what happens following the result will affect the lives of millions around the world. ...
The Summit of the Future is as ambitious as it sounds: it’s supposed to ‘retrofit the multilateral system to meet the challenges of the 21st Century’. What does that mean? Did they meet their aims? And what happens now? Dr Pasquine Ogunsanya and Clare Morrison were in New York, for the 79th Session of the UN General Assembly (UNGA79), where the Summit was held, to find out whether this really was a ‘once in a generation opportunity’...
Frontline AIDS’ Rapid Response Fund has received a $300,000 USD funding commitment from the Elton John AIDS Foundation (the Foundation) to tackle anti-gay and transphobic violence and rhetoric. ...
Frontline AIDS welcomes Gilead’s announcement to allow six generic manufacturers to sell its potentially game-changing HIV prevention drug, lenacapavir, while recognising that the treatment remains unaffordable to many. ...